Pharmaceutical firms put focus on more CI ads on trade papers

Published: 2004-02-24 06:59:00

Updated: 2004-02-24 06:59:00

Under slight prospects for an economic turnaround amid deepened business slump in a local pharmaceutical sector and less frequency of pharmacy visits by patients for purchase of nutrients, etc., local drug makers seem to remain largely reluctant to make public advertisements for boosting OTC sale...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK